VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q38639301  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000154.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q38639301‏
024 ‎‡a  0000-0001-5726-9797‏ ‎‡2  orcid‏
024 ‎‡a  56157112200‏ ‎‡2  scopus‏
024 ‎‡a  9246556000‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q38639301‏
100 0 ‎‡a  Jung Min Chang‏ ‎‡9  ast‏ ‎‡9  es‏ ‎‡9  sl‏
400 0 ‎‡a  Jung Min Chang‏ ‎‡c  researcher (ORCID 0000-0001-5726-9797)‏ ‎‡9  en‏
400 0 ‎‡a  Jung Min Chang‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes‏
670 ‎‡a  Author's A new full-field digital mammography system with and without the use of an advanced post-processing algorithm: comparison of image quality and diagnostic performance‏
670 ‎‡a  Author's Added value of shear-wave elastography for evaluation of breast masses detected with screening US imaging‏
670 ‎‡a  Author's Aliasing artifact depicted on ultrasound (US)-elastography for breast cystic lesions mimicking solid masses‏
670 ‎‡a  Author's An Effective Method to Reduce the Interpretation Time in the Clinical Use of Digital Breast Tomosynthesis‏
670 ‎‡a  Author's An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy‏
670 ‎‡a  Author's Association of tumour stiffness on sonoelastography with axillary nodal status in T1 breast carcinoma patients‏
670 ‎‡a  Author's Automated breast ultrasound system (ABUS): reproducibility of mass localization, size measurement, and characterization on serial examinations‏
670 ‎‡a  Author's Automated Breast Ultrasound System for Breast Cancer Evaluation: Diagnostic Performance of the Two-View Scan Technique in Women with Small Breasts‏
670 ‎‡a  Author's Automatic detection of microcalcifications in breast ultrasound‏
670 ‎‡a  Author's Axillary Nodal Evaluation in Breast Cancer: State of the Art‏
670 ‎‡a  Author's Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.‏
670 ‎‡a  Author's Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery‏
670 ‎‡a  Author's Biliary Complications in Living Donor Liver Transplantation: Imaging Findings and the Roles of Interventional Procedures‏
670 ‎‡a  Author's Breast cancer detected with screening US: reasons for nondetection at mammography‏
670 ‎‡a  Author's Breast cancers initially detected by hand-held ultrasound: detection performance of radiologists using automated breast ultrasound data‏
670 ‎‡a  Author's Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer‏
670 ‎‡a  Author's Breast mass evaluation: factors influencing the quality of US elastography‏
670 ‎‡a  Author's Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms‏
670 ‎‡a  Author's Characterization of breast lesions: comparison of digital breast tomosynthesis and ultrasonography‏
670 ‎‡a  Author's Classification of breast tumors using elastographic and B-mode features: comparison of automatic selection of representative slice and physician-selected slice of images‏
670 ‎‡a  Author's Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases‏
670 ‎‡a  Author's Columnar cell lesions without atypia initially diagnosed on breast needle biopsies: is imaging follow-up enough?‏
670 ‎‡a  Author's Comparative evaluation of average glandular dose and breast cancer detection between single-view digital breast tomosynthesis (DBT) plus single-view digital mammography (DM) and two-view DM: correlation with breast thickness and density‏
670 ‎‡a  Author's Comparison of Abbreviated MRI and Full Diagnostic MRI in Distinguishing between Benign and Malignant Lesions Detected by Breast MRI: A Multireader Study‏
670 ‎‡a  Author's Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer‏
670 ‎‡a  Author's Comparison of new and established full-field digital mammography systems in diagnostic performance‏
670 ‎‡a  Author's Comparison of shear-wave and strain ultrasound elastography in the differentiation of benign and malignant breast lesions.‏
670 ‎‡a  Author's Comparison of the diagnostic performance of digital breast tomosynthesis and magnetic resonance imaging added to digital mammography in women with known breast cancers‏
670 ‎‡a  Author's Comparison of two software versions of a commercially available computer-aided detection (CAD) system for detecting breast cancer‏
670 ‎‡a  Author's Computer-aided analysis of ultrasound elasticity images for classification of benign and malignant breast masses‏
670 ‎‡a  Author's Computer-aided classification of breast masses using speckle features of automated breast ultrasound images‏
670 ‎‡a  Author's Computer-aided detection in digital mammography: false-positive marks and their reproducibility in negative mammograms‏
670 ‎‡a  Author's Computer-aided detection system performance on current and previous digital mammograms in patients with contralateral metachronous breast cancer‏
670 ‎‡a  Author's Computer-aided diagnosis of breast masses using quantified BI-RADS findings‏
670 ‎‡a  Author's Computerized Segmentation and Classification of Breast Lesions Using Perfusion Volume Fractions in Dynamic Contrast-enhanced MRI‏
670 ‎‡a  Author's Contralateral lesions detected by preoperative MRI in patients with recently diagnosed breast cancer: application of MR CAD in differentiation of benign and malignant lesions‏
670 ‎‡a  Author's Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer.‏
670 ‎‡a  Author's Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers‏
670 ‎‡a  Author's Detection of axillary lymph node recurrence in patients with personal history of breast cancer treated with sentinel lymph node biopsy‏
670 ‎‡a  Author's Detection of axillary lymph node recurrence in patients with personal history of breast cancer treated with sentinel lymph node biopsy (SLNB): results of postoperative combined ultrasound and mammography screening over five consecutive years‏
670 ‎‡a  Author's Differentiation of benign from malignant solid breast masses: comparison of two-dimensional and three-dimensional shear-wave elastography‏
670 ‎‡a  Author's Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer‏
670 ‎‡a  Author's Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer‏
670 ‎‡a  Author's Does ultrasound-guided directional vacuum-assisted removal help eliminate abnormal nipple discharge in patients with benign intraductal single mass?‏
670 ‎‡a  Author's Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine‏
670 ‎‡a  Author's Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy: distinct patterns of response according to ER expression‏
670 ‎‡a  Author's Evaluation of a synthetic aperture technique for medical ultrasound imaging: Phantom and in vivo breast study‏
670 ‎‡a  Author's Evaluation of tumor extent in breast cancer patients using real-time MR navigated ultrasound: preliminary study‏
670 ‎‡a  Author's Evaluation of ultrasound synthetic aperture imaging using bidirectional pixel-based focusing: preliminary phantom and in vivo breast study.‏
670 ‎‡a  Author's False positive and false negative FDG-PET scans in various thoracic diseases‏
670 ‎‡a  Author's Intraductal mass on breast ultrasound: final outcomes and predictors of malignancy‏
670 ‎‡a  Author's Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model.‏
670 ‎‡a  Author's Location of triple-negative breast cancers: comparison with estrogen receptor-positive breast cancers on MR imaging‏
670 ‎‡a  Author's Low rates of additional cancer detection by magnetic resonance imaging in newly diagnosed breast cancer patients who undergo preoperative mammography and ultrasonography‏
670 ‎‡a  Author's Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model‏
670 ‎‡a  Author's Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine‏
670 ‎‡a  Author's Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status‏
670 ‎‡a  Author's Mammography and ultrasonography evaluation of unexpected focal 18F-FDG uptakes in breast on PET/CT.‏
670 ‎‡a  Author's Management of ultrasonographically detected benign papillomas of the breast at core needle biopsy‏
670 ‎‡a  Author's Outcome of breast lesions detected at screening ultrasonography‏
670 ‎‡a  Author's Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision‏
670 ‎‡a  Author's Patient age and tumor size determine the cancer yield of preoperative bilateral breast MRI in women with ductal carcinoma in situ‏
670 ‎‡a  Author's Pictorial review: Unusual tumours involving the prostate: radiological-pathological findings.‏
670 ‎‡a  Author's Practice guideline for the performance of breast ultrasound elastography‏
670 ‎‡a  Author's Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer‏
670 ‎‡a  Author's Quantitative analysis for breast density estimation in low dose chest CT scans‏
670 ‎‡a  Author's Quantitative analysis of breast echotexture patterns in automated breast ultrasound images‏
670 ‎‡a  Author's Quantitative ultrasound analysis for classification of BI-RADS category 3 breast masses‏
670 ‎‡a  Author's Radiofrequency ablation in pig lungs: in vivo comparison of internally cooled, perfusion and multitined expandable electrodes.‏
670 ‎‡a  Author's Radiofrequency ablation of the porcine liver in vivo: increased coagulation with an internally cooled perfusion electrode‏
670 ‎‡a  Author's Radiofrequency renal ablation: in vivo comparison of internally cooled, multitined expandable and internally cooled perfusion electrodes‏
670 ‎‡a  Author's Radiologists' performance in the detection of benign and malignant masses with 3D automated breast ultrasound (ABUS).‏
670 ‎‡a  Author's Rapid breast density analysis of partial volumes of automated breast ultrasound images‏
670 ‎‡a  Author's Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size‏
670 ‎‡a  Author's Risk of carcinoma after subsequent excision of benign papilloma initially diagnosed with an ultrasound (US)-guided 14-gauge core needle biopsy: a prospective observational study‏
670 ‎‡a  Author's Shear-wave elastographic features of breast cancers: comparison with mechanical elasticity and histopathologic characteristics‏
670 ‎‡a  Author's Shear-Wave Elastography for the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy‏
670 ‎‡a  Author's Sonoelastographic lesion stiffness: preoperative predictor of the presence of an invasive focus in nonpalpable DCIS diagnosed at US-guided needle biopsy‏
670 ‎‡a  Author's Sonoelastography for 1,786 non-palpable breast masses: diagnostic value in the decision to biopsy‏
670 ‎‡a  Author's Sonographic characteristics of breast cancers detected by supplemental screening US: Comparison with breast cancers seen on screening mammography‏
670 ‎‡a  Author's Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer‏
670 ‎‡a  Author's Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5 T and 3.0 T imaging for detection of focal malignant liver lesions.‏
670 ‎‡a  Author's Supplemental Breast US Screening in Women with a Personal History of Breast Cancer: A Matched Cohort Study‏
670 ‎‡a  Author's Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation‏
670 ‎‡a  Author's Synthetic aperture imaging in breast ultrasound: a preliminary clinical study‏
670 ‎‡a  Author's The detection of recurrent breast cancer in patients with a history of breast cancer surgery: comparison of clinical breast examination, mammography and ultrasonography‏
670 ‎‡a  Author's Tumor detection in automated breast ultrasound images using quantitative tissue clustering‏
670 ‎‡a  Author's Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound‏
670 ‎‡a  Author's Two-view versus single-view shear-wave elastography: comparison of observer performance in differentiating benign from malignant breast masses‏
670 ‎‡a  Author's Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement‏
670 ‎‡a  Author's Ultrasonographic assessment of breast density‏
670 ‎‡a  Author's Ultrasonography-guided vacuum-assisted biopsy of microcalcifications: Comparison of the diagnostic yield of calcified cores and non-calcified cores on specimen radiographs‏
670 ‎‡a  Author's Ultrasound-guided vacuum-assisted biopsy of microcalcifications detected at screening mammography‏
670 ‎‡a  Author's Ultrasound screening of contralateral breast after surgery for breast cancer‏
670 ‎‡a  Author's Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer‏
670 ‎‡a  Author's Utility and Diagnostic Performance of Automated Breast Ultrasound System in Evaluating Pure Non-Mass Enhancement on Breast Magnetic Resonance Imaging‏
670 ‎‡a  Author's Validation of a scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia using an ultrasound-guided core needle biopsy‏
670 ‎‡a  Author's Variability of breast density assessment in short-term reimaging with digital mammography‏
909 ‎‡a  (scopus) 9246556000‏ ‎‡9  1‏
909 ‎‡a  (scopus) 56157112200‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000157269797‏ ‎‡9  1‏
919 ‎‡a  2viewversussingleviewshearwaveelastographycomparisonofobserverperformanceindifferentiatingbenignfrommalignantbreastmasses‏ ‎‡A  Two-view versus single-view shear-wave elastography: comparison of observer performance in differentiating benign from malignant breast masses‏ ‎‡9  1‏
919 ‎‡a  tumourvolumedoublingtimeofmolecularbreastcancersubtypesassessedbyserialbreastultrasound‏ ‎‡A  Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound‏ ‎‡9  1‏
919 ‎‡a  tumordetectioninautomatedbreastultrasoundimagesusingquantitativetissueclustering‏ ‎‡A  Tumor detection in automated breast ultrasound images using quantitative tissue clustering‏ ‎‡9  1‏
919 ‎‡a  detectionofrecurrentbreastcancerinpatientswithahistoryofbreastcancersurgerycomparisonofclinicalbreastexaminationmammographyandultrasonography‏ ‎‡A  The detection of recurrent breast cancer in patients with a history of breast cancer surgery: comparison of clinical breast examination, mammography and ultrasonography‏ ‎‡9  1‏
919 ‎‡a  syntheticapertureimaginginbreastultrasoundapreliminaryclinicalstudy‏ ‎‡A  Synthetic aperture imaging in breast ultrasound: a preliminary clinical study‏ ‎‡9  1‏
919 ‎‡a  survivaloutcomesofbreastcancerpatientswhoreceiveneoadjuvantchemotherapyassociationwithdynamiccontrastenhancedmrimagingwithcomputeraidedevaluation‏ ‎‡A  Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation‏ ‎‡9  1‏
919 ‎‡a  supplementalbreastusscreeninginwomenwithapersonalhistoryofbreastcanceramatchedcohortstudy‏ ‎‡A  Supplemental Breast US Screening in Women with a Personal History of Breast Cancer: A Matched Cohort Study‏ ‎‡9  1‏
919 ‎‡a  superparamagneticironoxideenhancedlivermagneticresonanceimagingcomparisonof15tand30timagingfordetectionoffocalmalignantliverlesions‏ ‎‡A  Superparamagnetic iron oxide-enhanced liver magnetic resonance imaging: comparison of 1.5 T and 3.0 T imaging for detection of focal malignant liver lesions.‏ ‎‡9  1‏
919 ‎‡a  stiffnessoftumoursmeasuredbyshearwaveelastographycorrelatedwithsubtypesofbreastcancer‏ ‎‡A  Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer‏ ‎‡9  1‏
919 ‎‡a  sonographiccharacteristicsofbreastcancersdetectedbysupplementalscreeninguscomparisonwithbreastcancersseenonscreeningmammography‏ ‎‡A  Sonographic characteristics of breast cancers detected by supplemental screening US: Comparison with breast cancers seen on screening mammography‏ ‎‡9  1‏
919 ‎‡a  sonoelastographyfor1786nonpalpablebreastmassesdiagnosticvalueinthedecisiontobiopsy‏ ‎‡A  Sonoelastography for 1,786 non-palpable breast masses: diagnostic value in the decision to biopsy‏ ‎‡9  1‏
919 ‎‡a  sonoelastographiclesionstiffnesspreoperativepredictorofthepresenceofaninvasivefocusinnonpalpabledcisdiagnosedatusguidedneedlebiopsy‏ ‎‡A  Sonoelastographic lesion stiffness: preoperative predictor of the presence of an invasive focus in nonpalpable DCIS diagnosed at US-guided needle biopsy‏ ‎‡9  1‏
919 ‎‡a  shearwaveelastographyforthedetectionofresidualbreastcancerafterneoadjuvantchemotherapy‏ ‎‡A  Shear-Wave Elastography for the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy‏ ‎‡9  1‏
919 ‎‡a  shearwaveelastographicfeaturesofbreastcancerscomparisonwithmechanicalelasticityandhistopathologiccharacteristics‏ ‎‡A  Shear-wave elastographic features of breast cancers: comparison with mechanical elasticity and histopathologic characteristics‏ ‎‡9  1‏
919 ‎‡a  riskofcarcinomaaftersubsequentexcisionofbenignpapillomainitiallydiagnosedwithanultrasoundusguided14gaugecoreneedlebiopsyaprospectiveobservationalstudy‏ ‎‡A  Risk of carcinoma after subsequent excision of benign papilloma initially diagnosed with an ultrasound (US)-guided 14-gauge core needle biopsy: a prospective observational study‏ ‎‡9  1‏
919 ‎‡a  residualmammographicmicrocalcificationsandenhancinglesionsonmriafterneoadjuvantsystemicchemotherapyforlocallyadvancedbreastcancercorrelationwithhistopathologicresidualtumorsize‏ ‎‡A  Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size‏ ‎‡9  1‏
919 ‎‡a  rapidbreastdensityanalysisofpartialvolumesofautomatedbreastultrasoundimages‏ ‎‡A  Rapid breast density analysis of partial volumes of automated breast ultrasound images‏ ‎‡9  1‏
919 ‎‡a  radiologistsperformanceinthedetectionofbenignandmalignantmasseswith3dautomatedbreastultrasoundabus‏ ‎‡A  Radiologists' performance in the detection of benign and malignant masses with 3D automated breast ultrasound (ABUS).‏ ‎‡9  1‏
919 ‎‡a  radiofrequencyrenalablationinvivocomparisonofinternallycooledmultitinedexpandableandinternallycooledperfusionelectrodes‏ ‎‡A  Radiofrequency renal ablation: in vivo comparison of internally cooled, multitined expandable and internally cooled perfusion electrodes‏ ‎‡9  1‏
919 ‎‡a  radiofrequencyablationoftheporcineliverinvivoincreasedcoagulationwithaninternallycooledperfusionelectrode‏ ‎‡A  Radiofrequency ablation of the porcine liver in vivo: increased coagulation with an internally cooled perfusion electrode‏ ‎‡9  1‏
919 ‎‡a  radiofrequencyablationinpiglungsinvivocomparisonofinternallycooledperfusionandmultitinedexpandableelectrodes‏ ‎‡A  Radiofrequency ablation in pig lungs: in vivo comparison of internally cooled, perfusion and multitined expandable electrodes.‏ ‎‡9  1‏
919 ‎‡a  quantitativeultrasoundanalysisforclassificationofbiradscategory3breastmasses‏ ‎‡A  Quantitative ultrasound analysis for classification of BI-RADS category 3 breast masses‏ ‎‡9  1‏
919 ‎‡a  quantitativeanalysisofbreastechotexturepatternsinautomatedbreastultrasoundimages‏ ‎‡A  Quantitative analysis of breast echotexture patterns in automated breast ultrasound images‏ ‎‡9  1‏
919 ‎‡a  quantitativeanalysisforbreastdensityestimationinlowdosechestctscans‏ ‎‡A  Quantitative analysis for breast density estimation in low dose chest CT scans‏ ‎‡9  1‏
919 ‎‡a  predictingaxillaryresponsetoneoadjuvantchemotherapybreastmriandusinpatientswithnodepositivebreastcancer‏ ‎‡A  Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer‏ ‎‡9  1‏
919 ‎‡a  practiceguidelinefortheperformanceofbreastultrasoundelastography‏ ‎‡A  Practice guideline for the performance of breast ultrasound elastography‏ ‎‡9  1‏
919 ‎‡a  pictorialreviewunusualtumoursinvolvingtheprostateradiologicalpathologicalfindings‏ ‎‡A  Pictorial review: Unusual tumours involving the prostate: radiological-pathological findings.‏ ‎‡9  1‏
919 ‎‡a  patientageandtumorsizedeterminethecanceryieldofpreoperativebilateralbreastmriinwomenwithductalcarcinomainsitu‏ ‎‡A  Patient age and tumor size determine the cancer yield of preoperative bilateral breast MRI in women with ductal carcinoma in situ‏ ‎‡9  1‏
919 ‎‡a  papillarylesionsinitiallydiagnosedatultrasoundguidedvacuumassistedbreastbiopsyrateofmalignancybasedonsubsequentsurgicalexcision‏ ‎‡A  Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision‏ ‎‡9  1‏
919 ‎‡a  outcomeofbreastlesionsdetectedatscreeningultrasonography‏ ‎‡A  Outcome of breast lesions detected at screening ultrasonography‏ ‎‡9  1‏
919 ‎‡a  managementofultrasonographicallydetectedbenignpapillomasofthebreastatcoreneedlebiopsy‏ ‎‡A  Management of ultrasonographically detected benign papillomas of the breast at core needle biopsy‏ ‎‡9  1‏
919 ‎‡a  mammographyandultrasonographyevaluationofunexpectedfocal18ffdguptakesinbreastonpetct‏ ‎‡A  Mammography and ultrasonography evaluation of unexpected focal 18F-FDG uptakes in breast on PET/CT.‏ ‎‡9  1‏
919 ‎‡a  mammographicfeaturesofcalcificationsindciscorrelationwithoestrogenreceptorandhumanepidermalgrowthfactorreceptor2status‏ ‎‡A  Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status‏ ‎‡9  1‏
919 ‎‡a  magneticresonanceenhancementpatternanddiagnosticaccuracyofgadofluorine1000inarabbitvx2tumormodelcomparisonwithgadopentetatedimeglumine‏ ‎‡A  Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine‏ ‎‡9  1‏
919 ‎‡a  lymphnodemetastasesfromgastriccancergadofluorine1000andgadopentetatedimegluminemrimaginginarabbitmodel‏ ‎‡A  Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model‏ ‎‡9  1‏
919 ‎‡a  lowratesofadditionalcancerdetectionbymagneticresonanceimaginginnewlydiagnosedbreastcancerpatientswhoundergopreoperativemammographyandultrasonography‏ ‎‡A  Low rates of additional cancer detection by magnetic resonance imaging in newly diagnosed breast cancer patients who undergo preoperative mammography and ultrasonography‏ ‎‡9  1‏
919 ‎‡a  locationoftriplenegativebreastcancerscomparisonwithestrogenreceptorpositivebreastcancersonmrimaging‏ ‎‡A  Location of triple-negative breast cancers: comparison with estrogen receptor-positive breast cancers on MR imaging‏ ‎‡9  1‏
919 ‎‡a  localtoxicityofhepaticarterialinfusionofhexokinase2inhibitor3bromopyruvateinvivoinvestigationinnormalrabbitmodel‏ ‎‡A  Local toxicity of hepatic arterial infusion of hexokinase II inhibitor, 3-bromopyruvate: In vivo investigation in normal rabbit model.‏ ‎‡9  1‏
919 ‎‡a  intraductalmassonbreastultrasoundfinaloutcomesandpredictorsofmalignancy‏ ‎‡A  Intraductal mass on breast ultrasound: final outcomes and predictors of malignancy‏ ‎‡9  1‏
919 ‎‡a  falsepositiveandfalsenegativefdgpetscansinvariousthoracicdiseases‏ ‎‡A  False positive and false negative FDG-PET scans in various thoracic diseases‏ ‎‡9  1‏
919 ‎‡a  evaluationofultrasoundsyntheticapertureimagingusingbidirectionalpixelbasedfocusingpreliminaryphantomandinvivobreaststudy‏ ‎‡A  Evaluation of ultrasound synthetic aperture imaging using bidirectional pixel-based focusing: preliminary phantom and in vivo breast study.‏ ‎‡9  1‏
919 ‎‡a  evaluationoftumorextentinbreastcancerpatientsusingrealtimemrnavigatedultrasoundpreliminarystudy‏ ‎‡A  Evaluation of tumor extent in breast cancer patients using real-time MR navigated ultrasound: preliminary study‏ ‎‡9  1‏
919 ‎‡a  evaluationofasyntheticaperturetechniqueformedicalultrasoundimagingphantomandinvivobreaststudy‏ ‎‡A  Evaluation of a synthetic aperture technique for medical ultrasound imaging: Phantom and in vivo breast study‏ ‎‡9  1‏
919 ‎‡a  estrogenreceptorstatusconfersadistinctpatternofresponsetoneoadjuvantchemotherapyimplicationsforoptimaldurationsoftherapydistinctpatternsofresponseaccordingtoerexpression‏ ‎‡A  Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy: distinct patterns of response according to ER expression‏ ‎‡9  1‏
919 ‎‡a  dynamiccontrastenhancedmagneticresonanceimagingevaluationofvx2carcinomainarabbitmodelcomparisonof101000gadobutroland051000gadopentetatedimeglumine‏ ‎‡A  Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine‏ ‎‡9  1‏
919 ‎‡a  doesultrasoundguideddirectionalvacuumassistedremovalhelpeliminateabnormalnippledischargeinpatientswithbenignintraductalsinglemass‏ ‎‡A  Does ultrasound-guided directional vacuum-assisted removal help eliminate abnormal nipple discharge in patients with benign intraductal single mass?‏ ‎‡9  1‏
919 ‎‡a  diffusionweightedmriat30tfordetectionofoccultdiseaseinthecontralateralbreastinwomenwithnewlydiagnosedbreastcancer‏ ‎‡A  Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer‏ ‎‡9  1‏
919 ‎‡a  diffusionweightedmrimagingpretreatmentpredictionofresponsetoneoadjuvantchemotherapyinpatientswithbreastcancer‏ ‎‡A  Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer‏ ‎‡9  1‏
919 ‎‡a  differentiationofbenignfrommalignantsolidbreastmassescomparisonof2dimensionaland3dimensionalshearwaveelastography‏ ‎‡A  Differentiation of benign from malignant solid breast masses: comparison of two-dimensional and three-dimensional shear-wave elastography‏ ‎‡9  1‏
919 ‎‡a  detectionofaxillarylymphnoderecurrenceinpatientswithpersonalhistoryofbreastcancertreatedwithsentinellymphnodebiopsyslnbresultsofpostoperativecombinedultrasoundandmammographyscreeningover5consecutiveyears‏ ‎‡A  Detection of axillary lymph node recurrence in patients with personal history of breast cancer treated with sentinel lymph node biopsy (SLNB): results of postoperative combined ultrasound and mammography screening over five consecutive years‏ ‎‡9  1‏
919 ‎‡a  detectionofaxillarylymphnoderecurrenceinpatientswithpersonalhistoryofbreastcancertreatedwithsentinellymphnodebiopsy‏ ‎‡A  Detection of axillary lymph node recurrence in patients with personal history of breast cancer treated with sentinel lymph node biopsy‏ ‎‡9  1‏
919 ‎‡a  correlationofperfusionparametersondynamiccontrastenhancedmriwithprognosticfactorsandsubtypesofbreastcancers‏ ‎‡A  Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers‏ ‎‡9  1‏
919 ‎‡a  correctionbreastdensitychangeasapredictivesurrogateforresponsetoadjuvantendocrinetherapyinhormonereceptorpositivebreastcancer‏ ‎‡A  Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer.‏ ‎‡9  1‏
919 ‎‡a  contralaterallesionsdetectedbypreoperativemriinpatientswithrecentlydiagnosedbreastcancerapplicationofmrcadindifferentiationofbenignandmalignantlesions‏ ‎‡A  Contralateral lesions detected by preoperative MRI in patients with recently diagnosed breast cancer: application of MR CAD in differentiation of benign and malignant lesions‏ ‎‡9  1‏
919 ‎‡a  computerizedsegmentationandclassificationofbreastlesionsusingperfusionvolumefractionsindynamiccontrastenhancedmri‏ ‎‡A  Computerized Segmentation and Classification of Breast Lesions Using Perfusion Volume Fractions in Dynamic Contrast-enhanced MRI‏ ‎‡9  1‏
919 ‎‡a  computeraideddiagnosisofbreastmassesusingquantifiedbiradsfindings‏ ‎‡A  Computer-aided diagnosis of breast masses using quantified BI-RADS findings‏ ‎‡9  1‏
919 ‎‡a  computeraideddetectionsystemperformanceoncurrentandpreviousdigitalmammogramsinpatientswithcontralateralmetachronousbreastcancer‏ ‎‡A  Computer-aided detection system performance on current and previous digital mammograms in patients with contralateral metachronous breast cancer‏ ‎‡9  1‏
919 ‎‡a  computeraideddetectionindigitalmammographyfalsepositivemarksandtheirreproducibilityinnegativemammograms‏ ‎‡A  Computer-aided detection in digital mammography: false-positive marks and their reproducibility in negative mammograms‏ ‎‡9  1‏
919 ‎‡a  computeraidedclassificationofbreastmassesusingspecklefeaturesofautomatedbreastultrasoundimages‏ ‎‡A  Computer-aided classification of breast masses using speckle features of automated breast ultrasound images‏ ‎‡9  1‏
919 ‎‡a  computeraidedanalysisofultrasoundelasticityimagesforclassificationofbenignandmalignantbreastmasses‏ ‎‡A  Computer-aided analysis of ultrasound elasticity images for classification of benign and malignant breast masses‏ ‎‡9  1‏
919 ‎‡a  comparisonof2softwareversionsofacommerciallyavailablecomputeraideddetectioncadsystemfordetectingbreastcancer‏ ‎‡A  Comparison of two software versions of a commercially available computer-aided detection (CAD) system for detecting breast cancer‏ ‎‡9  1‏
919 ‎‡a  comparisonofthediagnosticperformanceofdigitalbreasttomosynthesisandmagneticresonanceimagingaddedtodigitalmammographyinwomenwithknownbreastcancers‏ ‎‡A  Comparison of the diagnostic performance of digital breast tomosynthesis and magnetic resonance imaging added to digital mammography in women with known breast cancers‏ ‎‡9  1‏
919 ‎‡a  comparisonofshearwaveandstrainultrasoundelastographyinthedifferentiationofbenignandmalignantbreastlesions‏ ‎‡A  Comparison of shear-wave and strain ultrasound elastography in the differentiation of benign and malignant breast lesions.‏ ‎‡9  1‏
919 ‎‡a  comparisonofnewandestablishedfullfielddigitalmammographysystemsindiagnosticperformance‏ ‎‡A  Comparison of new and established full-field digital mammography systems in diagnostic performance‏ ‎‡9  1‏
919 ‎‡a  comparisonofdiffusionweightedmrimagingandfdgpetcttopredictpathologicalcompleteresponsetoneoadjuvantchemotherapyinpatientswithbreastcancer‏ ‎‡A  Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer‏ ‎‡9  1‏
919 ‎‡a  comparisonofabbreviatedmriandfulldiagnosticmriindistinguishingbetweenbenignandmalignantlesionsdetectedbybreastmriamultireaderstudy‏ ‎‡A  Comparison of Abbreviated MRI and Full Diagnostic MRI in Distinguishing between Benign and Malignant Lesions Detected by Breast MRI: A Multireader Study‏ ‎‡9  1‏
919 ‎‡a  comparativeevaluationofaverageglandulardoseandbreastcancerdetectionbetweensingleviewdigitalbreasttomosynthesisdbtplussingleviewdigitalmammographydmand2viewdmcorrelationwithbreastthicknessanddensity‏ ‎‡A  Comparative evaluation of average glandular dose and breast cancer detection between single-view digital breast tomosynthesis (DBT) plus single-view digital mammography (DM) and two-view DM: correlation with breast thickness and density‏ ‎‡9  1‏
919 ‎‡a  columnarcelllesionswithoutatypiainitiallydiagnosedonbreastneedlebiopsiesisimagingfollowupenough‏ ‎‡A  Columnar cell lesions without atypia initially diagnosed on breast needle biopsies: is imaging follow-up enough?‏ ‎‡9  1‏
919 ‎‡a  clinicalapplicationofshearwaveelastographysweinthediagnosisofbenignandmalignantbreastdiseases‏ ‎‡A  Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases‏ ‎‡9  1‏
919 ‎‡a  classificationofbreasttumorsusingelastographicandbmodefeaturescomparisonofautomaticselectionofrepresentativesliceandphysicianselectedsliceofimages‏ ‎‡A  Classification of breast tumors using elastographic and B-mode features: comparison of automatic selection of representative slice and physician-selected slice of images‏ ‎‡9  1‏
919 ‎‡a  characterizationofbreastlesionscomparisonofdigitalbreasttomosynthesisandultrasonography‏ ‎‡A  Characterization of breast lesions: comparison of digital breast tomosynthesis and ultrasonography‏ ‎‡9  1‏
919 ‎‡a  characteristicsofbreastcancersdetectedbyultrasoundscreeninginwomenwithnegativemammograms‏ ‎‡A  Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms‏ ‎‡9  1‏
919 ‎‡a  breastmassevaluationfactorsinfluencingthequalityofuselastography‏ ‎‡A  Breast mass evaluation: factors influencing the quality of US elastography‏ ‎‡9  1‏
919 ‎‡a  breastdensitychangeasapredictivesurrogateforresponsetoadjuvantendocrinetherapyinhormonereceptorpositivebreastcancer‏ ‎‡A  Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer‏ ‎‡9  1‏
919 ‎‡a  breastcancersinitiallydetectedbyhandheldultrasounddetectionperformanceofradiologistsusingautomatedbreastultrasounddata‏ ‎‡A  Breast cancers initially detected by hand-held ultrasound: detection performance of radiologists using automated breast ultrasound data‏ ‎‡9  1‏
919 ‎‡a  breastcancerdetectedwithscreeningusreasonsfornondetectionatmammography‏ ‎‡A  Breast cancer detected with screening US: reasons for nondetection at mammography‏ ‎‡9  1‏
919 ‎‡a  biliarycomplicationsinlivingdonorlivertransplantationimagingfindingsandtherolesofinterventionalprocedures‏ ‎‡A  Biliary Complications in Living Donor Liver Transplantation: Imaging Findings and the Roles of Interventional Procedures‏ ‎‡9  1‏
919 ‎‡a  backgroundparenchymalsignalenhancementratioatpreoperativemrimagingassociationwithsubsequentlocalrecurrenceinpatientswithductalcarcinomainsituafterbreastconservationsurgery‏ ‎‡A  Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery‏ ‎‡9  1‏
919 ‎‡a  background18ffdguptakeinpositronemissionmammographypemcorrelationwithmammographicdensityandbackgroundparenchymalenhancementinbreastmri‏ ‎‡A  Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.‏ ‎‡9  1‏
919 ‎‡a  axillarynodalevaluationinbreastcancerstateoftheart‏ ‎‡A  Axillary Nodal Evaluation in Breast Cancer: State of the Art‏ ‎‡9  1‏
919 ‎‡a  automaticdetectionofmicrocalcificationsinbreastultrasound‏ ‎‡A  Automatic detection of microcalcifications in breast ultrasound‏ ‎‡9  1‏
919 ‎‡a  automatedbreastultrasoundsystemforbreastcancerevaluationdiagnosticperformanceofthe2viewscantechniqueinwomenwithsmallbreasts‏ ‎‡A  Automated Breast Ultrasound System for Breast Cancer Evaluation: Diagnostic Performance of the Two-View Scan Technique in Women with Small Breasts‏ ‎‡9  1‏
919 ‎‡a  automatedbreastultrasoundsystemabusreproducibilityofmasslocalizationsizemeasurementandcharacterizationonserialexaminations‏ ‎‡A  Automated breast ultrasound system (ABUS): reproducibility of mass localization, size measurement, and characterization on serial examinations‏ ‎‡9  1‏
919 ‎‡a  associationoftumourstiffnessonsonoelastographywithaxillarynodalstatusint1breastcarcinomapatients‏ ‎‡A  Association of tumour stiffness on sonoelastography with axillary nodal status in T1 breast carcinoma patients‏ ‎‡9  1‏
919 ‎‡a  hrmasmrmetabolomicsstudyonbreasttissuesobtainedwithcoreneedlebiopsy‏ ‎‡A  An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy‏ ‎‡9  1‏
919 ‎‡a  effectivemethodtoreducetheinterpretationtimeintheclinicaluseofdigitalbreasttomosynthesis‏ ‎‡A  An Effective Method to Reduce the Interpretation Time in the Clinical Use of Digital Breast Tomosynthesis‏ ‎‡9  1‏
919 ‎‡a  aliasingartifactdepictedonultrasounduselastographyforbreastcysticlesionsmimickingsolidmasses‏ ‎‡A  Aliasing artifact depicted on ultrasound (US)-elastography for breast cystic lesions mimicking solid masses‏ ‎‡9  1‏
919 ‎‡a  addedvalueofshearwaveelastographyforevaluationofbreastmassesdetectedwithscreeningusimaging‏ ‎‡A  Added value of shear-wave elastography for evaluation of breast masses detected with screening US imaging‏ ‎‡9  1‏
919 ‎‡a  newfullfielddigitalmammographysystemwithandwithouttheuseofanadvancedpostprocessingalgorithmcomparisonofimagequalityanddiagnosticperformance‏ ‎‡A  A new full-field digital mammography system with and without the use of an advanced post-processing algorithm: comparison of image quality and diagnostic performance‏ ‎‡9  1‏
919 ‎‡a  18ffdguptakeinbreastcancercorrelateswithimmunohistochemicallydefinedsubtypes‏ ‎‡A  18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes‏ ‎‡9  1‏
919 ‎‡a  variabilityofbreastdensityassessmentinshorttermreimagingwithdigitalmammography‏ ‎‡A  Variability of breast density assessment in short-term reimaging with digital mammography‏ ‎‡9  1‏
919 ‎‡a  validationofascoringsystemforpredictingmalignancyinpatientsdiagnosedwithatypicalductalhyperplasiausinganultrasoundguidedcoreneedlebiopsy‏ ‎‡A  Validation of a scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia using an ultrasound-guided core needle biopsy‏ ‎‡9  1‏
919 ‎‡a  utilityanddiagnosticperformanceofautomatedbreastultrasoundsysteminevaluatingpurenonmassenhancementonbreastmagneticresonanceimaging‏ ‎‡A  Utility and Diagnostic Performance of Automated Breast Ultrasound System in Evaluating Pure Non-Mass Enhancement on Breast Magnetic Resonance Imaging‏ ‎‡9  1‏
919 ‎‡a  unilateralbreastcancerscreeningofcontralateralbreastbyusingpreoperativemrimagingreducesincidenceofmetachronouscancer‏ ‎‡A  Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer‏ ‎‡9  1‏
919 ‎‡a  ultrasoundscreeningofcontralateralbreastaftersurgeryforbreastcancer‏ ‎‡A  Ultrasound screening of contralateral breast after surgery for breast cancer‏ ‎‡9  1‏
919 ‎‡a  ultrasoundguidedvacuumassistedbiopsyofmicrocalcificationsdetectedatscreeningmammography‏ ‎‡A  Ultrasound-guided vacuum-assisted biopsy of microcalcifications detected at screening mammography‏ ‎‡9  1‏
919 ‎‡a  ultrasonographyguidedvacuumassistedbiopsyofmicrocalcificationscomparisonofthediagnosticyieldofcalcifiedcoresandnoncalcifiedcoresonspecimenradiographs‏ ‎‡A  Ultrasonography-guided vacuum-assisted biopsy of microcalcifications: Comparison of the diagnostic yield of calcified cores and non-calcified cores on specimen radiographs‏ ‎‡9  1‏
919 ‎‡a  ultrasonographicassessmentofbreastdensity‏ ‎‡A  Ultrasonographic assessment of breast density‏ ‎‡9  1‏
919 ‎‡a  ultrafastdynamiccontrastenhancedbreastmrilesionconspicuityandsizeassessmentaccordingtobackgroundparenchymalenhancement‏ ‎‡A  Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement‏ ‎‡9  1‏
996 ‎‡2  BIBSYS|90648512‏
996 ‎‡2  ISNI|0000000492601160‏
996 ‎‡2  ISNI|0000000475018934‏
996 ‎‡2  ISNI|000000042787818X‏
996 ‎‡2  NSK|000466170‏
996 ‎‡2  LC|n 85308988‏
996 ‎‡2  ISNI|0000000477802490‏
996 ‎‡2  LC|no2013093522‏
996 ‎‡2  CYT|AC000529284‏
996 ‎‡2  NII|DA00810361‏
996 ‎‡2  ISNI|0000000083917631‏
996 ‎‡2  LC|n 85307481‏
996 ‎‡2  LC|nr 95010930‏
996 ‎‡2  BIBSYS|90276563‏
996 ‎‡2  LC|nb2006028031‏
996 ‎‡2  ICCU|VIAV096167‏
996 ‎‡2  SUDOC|066937086‏
996 ‎‡2  DNB|119010836‏
996 ‎‡2  ISNI|0000000464928430‏
996 ‎‡2  NLR|RU NLR AUTH 7773382‏
996 ‎‡2  ISNI|0000000082375762‏
996 ‎‡2  CYT|AC000002252‏
996 ‎‡2  CYT|AC000229299‏
996 ‎‡2  ISNI|0000000063314788‏
996 ‎‡2  BIBSYS|99017374‏
996 ‎‡2  ISNI|0000000064297406‏
996 ‎‡2  BNF|16166705‏
996 ‎‡2  LC|nr 94018202‏
996 ‎‡2  ISNI|0000000064365472‏
996 ‎‡2  LC|no 97055217‏
996 ‎‡2  LC|no2013005453‏
996 ‎‡2  BNF|12005780‏
996 ‎‡2  ISNI|0000000464820358‏
996 ‎‡2  BNF|15089513‏
996 ‎‡2  LC|n 83024693‏
996 ‎‡2  SUDOC|031383688‏
996 ‎‡2  DNB|1089693567‏
996 ‎‡2  ISNI|0000000063688763‏
996 ‎‡2  ISNI|0000000063627231‏
996 ‎‡2  ISNI|0000000023534874‏
996 ‎‡2  LC|n 86112793‏
996 ‎‡2  ISNI|0000000472591495‏
996 ‎‡2  NTA|073199818‏
996 ‎‡2  ISNI|0000000461089619‏
996 ‎‡2  ISNI|0000000464911831‏
996 ‎‡2  DNB|131838799X‏
996 ‎‡2  LC|nr 89010381‏
996 ‎‡2  NUKAT|n 2016088926‏
996 ‎‡2  CYT|AC000184392‏
996 ‎‡2  SUDOC|227980794‏
996 ‎‡2  LC|nr 88003866‏
996 ‎‡2  ISNI|0000000459427682‏
996 ‎‡2  LC|n 78096405‏
996 ‎‡2  LC|nr 97011530‏
996 ‎‡2  ISNI|0000000063044802‏
996 ‎‡2  RERO|A000034181‏
996 ‎‡2  BNF|14108439‏
996 ‎‡2  ISNI|0000000464925942‏
996 ‎‡2  NKC|uk20191052695‏
996 ‎‡2  LC|n 89605283‏
996 ‎‡2  LC|n 85213366‏
996 ‎‡2  CYT|AC000253168‏
996 ‎‡2  ISNI|0000000063836383‏
996 ‎‡2  ISNI|0000000064356007‏
996 ‎‡2  LNB|LNC10-000090933‏
996 ‎‡2  LC|n 85203443‏
996 ‎‡2  ISNI|0000000064207052‏
996 ‎‡2  LC|n 85136366‏
996 ‎‡2  LC|n 89118099‏
996 ‎‡2  BIBSYS|90058072‏
996 ‎‡2  NKC|utb20181017886‏
996 ‎‡2  PLWABN|9810630860905606‏
996 ‎‡2  ISNI|0000000474210254‏
996 ‎‡2  SUDOC|028666879‏
996 ‎‡2  ISNI|0000000078702732‏
996 ‎‡2  SELIBR|344891‏
996 ‎‡2  NDL|00626985‏
996 ‎‡2  ISNI|0000000504640619‏
996 ‎‡2  NII|DA15117420‏
996 ‎‡2  ISNI|000000006425721X‏
996 ‎‡2  ISNI|0000000064302615‏
996 ‎‡2  ISNI|0000000063823961‏
996 ‎‡2  SUDOC|19643260X‏
996 ‎‡2  DBC|87097968202280‏
996 ‎‡2  J9U|987007428702405171‏
996 ‎‡2  NUKAT|n 2016136535‏
996 ‎‡2  ISNI|0000000064348795‏
996 ‎‡2  BIBSYS|13014367‏
996 ‎‡2  J9U|987007259698105171‏
996 ‎‡2  ISNI|0000000063692615‏
996 ‎‡2  J9U|987009347872705171‏
996 ‎‡2  LC|nr 98002785‏
996 ‎‡2  ISNI|000000006405659X‏
996 ‎‡2  LC|nr 93021057‏
996 ‎‡2  ISNI|0000000051114295‏
996 ‎‡2  NUKAT|n 96003325‏
996 ‎‡2  DNB|1279558156‏
996 ‎‡2  CAOONL|ncf10698854‏
996 ‎‡2  ISNI|0000000464885426‏
996 ‎‡2  LC|n 80110920‏
996 ‎‡2  J9U|987007409080805171‏
996 ‎‡2  LC|no 96047362‏
996 ‎‡2  EGAXA|vtls003322563‏
996 ‎‡2  DNB|1327955857‏
996 ‎‡2  CYT|AC000001667‏
996 ‎‡2  NII|DA06819245‏
996 ‎‡2  ISNI|0000000474004127‏
996 ‎‡2  CYT|AC000004247‏
996 ‎‡2  J9U|987012749235405171‏
996 ‎‡2  CYT|AC000579240‏
996 ‎‡2  ISNI|000000006369360X‏
996 ‎‡2  BNE|XX886294‏
996 ‎‡2  CAOONL|ncf11467466‏
996 ‎‡2  J9U|987007276026205171‏
996 ‎‡2  LC|n 85176547‏
996 ‎‡2  CYT|AC000025963‏
996 ‎‡2  J9U|987007435247905171‏
996 ‎‡2  DNB|1089096631‏
996 ‎‡2  LC|n 84140609‏
996 ‎‡2  LC|n 2018032567‏
996 ‎‡2  W2Z|90648512‏
996 ‎‡2  ISNI|0000000063632858‏
996 ‎‡2  DNB|1337936642‏
996 ‎‡2  LC|n 81150363‏
996 ‎‡2  LC|n 88177921‏
996 ‎‡2  ISNI|0000000084745704‏
996 ‎‡2  LC|n 98058445‏
996 ‎‡2  LC|n 82150076‏
996 ‎‡2  LC|n 2012018266‏
996 ‎‡2  ISNI|0000000034310219‏
996 ‎‡2  ISNI|000000043959634X‏
996 ‎‡2  LC|no2015000460‏
996 ‎‡2  DNB|140257683‏
996 ‎‡2  BNCHL|10000000000000000833700‏
996 ‎‡2  LC|no2012058017‏
996 ‎‡2  LC|n 84220903‏
996 ‎‡2  NDL|00435697‏
996 ‎‡2  LNL|11626‏
996 ‎‡2  NTA|364176520‏
996 ‎‡2  NSK|000197347‏
996 ‎‡2  BIBSYS|3104235‏
996 ‎‡2  DNB|1089635982‏
996 ‎‡2  BNC|981058521475706706‏
996 ‎‡2  CAOONL|ncf12118105‏
996 ‎‡2  CYT|AC000008652‏
996 ‎‡2  N6I|vtls000315448‏
996 ‎‡2  LC|nr 97030501‏
996 ‎‡2  NTA|43307390X‏
996 ‎‡2  CYT|AC000228860‏
996 ‎‡2  CYT|AC000228861‏
996 ‎‡2  LC|nr 92002543‏
996 ‎‡2  LC|no2010134113‏
996 ‎‡2  LC|n 85213804‏
996 ‎‡2  ISNI|0000000064367902‏
996 ‎‡2  ISNI|000000006339962X‏
996 ‎‡2  NLR|RU NLR AUTH 770159996‏
996 ‎‡2  CAOONL|ncf11044661‏
996 ‎‡2  ISNI|0000000109273345‏
996 ‎‡2  ISNI|0000000063488761‏
996 ‎‡2  LC|n 81142829‏
996 ‎‡2  NKC|jn19990003799‏
996 ‎‡2  SUDOC|14790949X‏
996 ‎‡2  ISNI|0000000063550748‏
996 ‎‡2  LC|n 88016049‏
996 ‎‡2  LC|nr 98002578‏
996 ‎‡2  LC|nr 95008739‏
996 ‎‡2  BLBNB|000157135‏
996 ‎‡2  DNB|1139847341‏
996 ‎‡2  ISNI|0000000063114970‏
996 ‎‡2  LC|n 86031063‏
996 ‎‡2  BIBSYS|98070754‏
996 ‎‡2  ISNI|0000000398924422‏
996 ‎‡2  CYT|AC000226154‏
996 ‎‡2  LC|n 2007027996‏
996 ‎‡2  CYT|AC000228859‏
996 ‎‡2  CYT|AC000595943‏
996 ‎‡2  LC|n 2014009784‏
996 ‎‡2  LC|n 79012979‏
996 ‎‡2  DNB|142567051‏
996 ‎‡2  ISNI|000000036781209X‏
996 ‎‡2  LC|n 82132230‏
996 ‎‡2  NDL|00317921‏
996 ‎‡2  KRNLK|KAC200811288‏
996 ‎‡2  NSK|000746934‏
996 ‎‡2  DNB|128499052‏
996 ‎‡2  ISNI|000000008171753X‏
996 ‎‡2  ISNI|0000000126921412‏
996 ‎‡2  ISNI|000000010452431X‏
996 ‎‡2  LC|nr 95010775‏
996 ‎‡2  ISNI|0000000120207031‏
996 ‎‡2  LC|no2014099167‏
996 ‎‡2  ISNI|0000000079862666‏
996 ‎‡2  CYT|AC000252680‏
996 ‎‡2  LIH|LNB:BW_d_N;=B_h_‏
996 ‎‡2  LC|n 81059881‏
996 ‎‡2  NII|DA03147479‏
996 ‎‡2  ISNI|0000000504524802‏
996 ‎‡2  ISNI|0000000464258828‏
996 ‎‡2  J9U|987007320179905171‏
996 ‎‡2  LC|no2014002945‏
996 ‎‡2  LC|n 2022061021‏
996 ‎‡2  ISNI|0000000063780922‏
996 ‎‡2  ISNI|0000000063391863‏
996 ‎‡2  BNF|12260876‏
996 ‎‡2  J9U|987007323562705171‏
996 ‎‡2  ISNI|0000000493064731‏
996 ‎‡2  ISNI|0000000464381789‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏